During the past decade, CHU de Fort-de-France conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 1 clinical trials were completed, i.e. on average, 14.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "CHU de Fort-de-France" #1 sponsor was "Actelion" with 2 trials, followed by "Federation Francophone de Cancerologie Digestive" with 2 trials sponsored, "ADDMEDICA SASA" with 1 trials sponsored, "Biotronik France" with 1 trials sponsored and "Central Hospital, Nancy, France" with 1 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "CHU de Fort-de-France" #1 collaborator was "Amgen" with 1 trials as a collaborator, "GERCOR - Multidisciplinary Oncology Cooperative Group" with 1 trials as a collaborator, "Sanofi" with 1 trials as a collaborator and "UNICANCER" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "CHU de Fort-de-France" are "Pulmonary Hypertension" (2 trials), "Cancer of Prostate" (1 trials), "Cardiovascular Disease" (1 trials), "Coronary Artery Diseases" (1 trials) and "Diabetes" (1 trials). Many other conditions were trialed in "CHU de Fort-de-France" in a lesser frequency.

Most popular intervention types in "CHU de Fort-de-France" are "Drug" (5 trials), "Combination Product" (2 trials), "Device" (2 trials), "Other" (2 trials) and "Genetic" (1 trials). Other intervention types were less common.

The name of intervention was led by "5Fluorouracil bolus" (1 trials), "5Fluorouracil continu" (1 trials), "Balloon catheter + oral misoprostol" (1 trials), "Blood sample" (1 trials) and "Bosentan" (1 trials). Other intervention names were less common.

The vast majority of trials in "CHU de Fort-de-France" are 13 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "CHU de Fort-de-France". undefined are not yet recruiting, 5 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in CHU de Fort-de-France, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in CHU de Fort-de-France, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".